Skip Navigation



Rheumatology Advance Access published online on March 31, 2003

Rheumatology, doi:10.1093/rheumatology/keg255
Rheumatology © British Society for Rheumatology 2003; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
42/8/935    most recent
keg255v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Uhm, W.-S.
Right arrow Articles by Yoo, D.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uhm, W.-S.
Right arrow Articles by Yoo, D.-H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 British Society for Rheumatology

Original Papers

Cytokine balance in kidney tissue from lupus nephritis patients

W.-S. Uhm 1, K. Na 2, G.-W. Song 3, S.-S. Jung 2, T. Lee 4, M.-H. Park 3, D.-H. Yoo 2*

1 Hospital for Rheumatic Diseases; Present address: Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University Boocheon Hospital, Boocheon, Korea
2 Hospital for Rheumatic Diseases
3 Department of Pathology, College of Medicine, Hanyang University, Seoul, Korea
4 Department of Urology, College of Medicine, Hanyang University

* Corresponding author. E-mail: dhyoo{at}hanyang.ac.kr.

Received 16 May 2002 ; accepted 20 December 2002

Abstract

Objective. To identify the balance of Th1/Th2 cytokine expression in the kidney and evaluate the difference in cytokine balance between patients with lupus nephritis WHO classes IV and V.

Methods. The expression of the CD40 molecule on cultured human mesangial cells was assessed by flow cytometry after stimulation with interferon {gamma} (IFN-{gamma}) or other cytokines. Frozen sections of kidney tissue from 10 patients with lupus nephritis and two non-SLE patients (with minimal-change disease) were stained with monoclonal antibodies for interleukin (IL)-4, IL-10, IL-12, IFN-{gamma}, CD4, CD8, CD40, CD68 and CD40L.

Results. CD40 expression of cultured mesangial cells was up-regulated by IFN-{gamma}, but was not down-regulated in the presence of the Th2 cytokines IL-4 and IL-10. In the glomeruli, CD40 expression and the ratios of IFN-{gamma}-/IL-10-, IL-12-/IL-4- and (IFN-{gamma}+IL-12)/(IL-4+IL-10)-positive cells were significantly higher in class IV than in class V lupus nephritis (P < 0.05). Also CD40, IFN-{gamma} and the activity index derived from the renal biopsy were closely correlated.

Conclusion. IFN-{gamma} may contribute to the pathogenesis of proliferative glomerulonephritis by the up-regulation of CD40 and the activation of the cellular immune response in human lupus.

Key words: Systemic lupus erythematosus, Cytokine, Interferon-{gamma}, Lupus nephritis, CD40.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Harigai, M. Kawamoto, M. Hara, T. Kubota, N. Kamatani, and N. Miyasaka
Excessive Production of IFN-{gamma} in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B
J. Immunol., August 1, 2008; 181(3): 2211 - 2219.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.